Execution Version INTERCEPT PHARMACEUTICALS, INC. THIRD amended and restated stockholders agreementStockholders Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Third Amended and Restated Stockholders Agreement (the “Agreement”) dated as of August 9, 2012 is entered into by and among INTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), the New Investors listed on Exhibit A hereto (each a “New Investor” and collectively the “New Investors”) the persons listed on Exhibit B hereto (each a “Founder,” and collectively the “Founders”), and each entity and individual listed on Exhibit C hereto (the “Prior Investors” and each, a “Prior Investor”).
INTERCEPT PHARMACEUTICALS, INC. THIRD amended and restated stockholders agreementStockholders Agreement • September 4th, 2012 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 4th, 2012 Company Industry JurisdictionThis Third Amended and Restated Stockholders Agreement (the “Agreement”) dated as of August 9, 2012 is entered into by and among INTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), the New Investors listed on Exhibit A hereto (each a “New Investor” and collectively the “New Investors”) the persons listed on Exhibit B hereto (each a “Founder,” and collectively the “Founders”), and each entity and individual listed on Exhibit C hereto (the “Prior Investors” and each, a “Prior Investor”).